Tumor microenvironment: becoming sick of Myc

被引:60
作者
Whitfield, Jonathan R. [1 ]
Soucek, Laura [1 ]
机构
[1] Vall Hebron Inst Oncol VHIO, Barcelona 08035, Spain
关键词
Myc; Omomyc; Cancer; Microenvironment; Tumorigenesis; Inflammation; Angiogenesis; C-MYC; PROGNOSTIC VALUE; ANGIOGENESIS; CELLS; ONCOGENE; MYC/MAX/MAD; EXPRESSION; REGRESSION; PROTEIN; OXYGEN;
D O I
10.1007/s00018-011-0860-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several years ago, we described Myc as "the oncogene from hell", since evidence had just emerged that Myc, aside from being responsible for cell-cycle progression and tumor expansion, was also able to induce genomic instability in culture, wreaking havoc in tumor cells and accelerating tumor progression (Soucek and Evan, Cancer Cell 1:406-408, 2002; Vafa et al., Mol Cell 9:1031-1044, 2002). In this review, we discuss recent publications that expand Myc's evil armory to include coordination of the crosstalk between tumor and microenvironment. Indeed, endogenous Myc, acting as a client for upstream oncogenic lesions, instructs the tumor stroma, engages a complex inflammatory response and induces angiogenesis, thus allowing the tumor to thrive. This is highly topical in light of the fact that Hanahan and Weinberg have recently redefined the hallmarks of cancer and pointed out that genomic instability and inflammation are essential for both their acquisition and development (Hanahan and Weinberg, Cell 144:646-674, 2011). Myc, it seems, is behind it all.
引用
收藏
页码:931 / 934
页数:4
相关论文
共 37 条
[1]   MYC in Oncogenesis and as a Target for Cancer Therapies [J].
Albihn, Ami ;
Johnsen, John Inge ;
Henriksson, Marie Arsenian .
ADVANCES IN CANCER RESEARCH, VOL 107, 2010, 107 :163-224
[2]   c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression [J].
Baudino, TA ;
McKay, C ;
Pendeville-Samain, H ;
Nilsson, JA ;
Maclean, KH ;
White, EL ;
Davis, AC ;
Ihle, JN ;
Cleveland, JL .
GENES & DEVELOPMENT, 2002, 16 (19) :2530-2543
[3]   Modes of resistance to anti-angiogenic therapy [J].
Bergers, Gabriele ;
Hanahan, Douglas .
NATURE REVIEWS CANCER, 2008, 8 (08) :592-603
[4]   PROGNOSTIC VALUE OF C-MYC PROTOONCOGENE OVEREXPRESSION IN EARLY INVASIVE-CARCINOMA OF THE CERVIX [J].
BOURHIS, J ;
LE, MG ;
BARROIS, M ;
GERBAULET, A ;
JEANNEL, D ;
DUVILLARD, P ;
LEDOUSSAL, V ;
CHASSAGNE, D ;
RIOU, G .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (11) :1789-1796
[5]  
CHRISTOFORI G, 1994, SEMIN CANCER BIOL, V5, P3
[6]   Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster [J].
Dews, Michael ;
Homayouni, Asal ;
Yu, Duonan ;
Murphy, Danielle ;
Sevignani, Cinzia ;
Wentzel, Erik ;
Furth, Emma E. ;
Lee, William M. ;
Enders, Greg H. ;
T Mendell, Joshua ;
Thomas-Tikhonenko, Andrei .
NATURE GENETICS, 2006, 38 (09) :1060-1065
[7]  
Gallant P, 2006, CURR TOP MICROBIOL, V302, P235
[8]   Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch [J].
Giuriato, Sylvie ;
Ryeom, Sandra ;
Fan, Alice C. ;
Bachireddy, Pavan ;
Lynch, Ryan C. ;
Rioth, Matthew J. ;
van Riggelen, Jan ;
Kopelman, Andrew M. ;
Passegue, Emmanuelle ;
Tang, Flora ;
Folkman, Judah ;
Felsher, Dean W. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (44) :16266-16271
[9]   HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation [J].
Gordan, John D. ;
Thompson, Craig B. ;
Simon, M. Celeste .
CANCER CELL, 2007, 12 (02) :108-113
[10]   The Myc/Max/Mad network and the transcriptional control of cell behavior [J].
Grandori, C ;
Cowley, SM ;
James, LP ;
Eisenman, RN .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2000, 16 :653-699